LE

Luke Evnin

Managing Director, MPM Capital; Chairman, Scleroderma Research Foundation; Proprietor, Annulus Cellars

United States

VC
Investor

Invests in

  • Min Investment:

    $1,000,000.00

  • Max Investment:

    $150,000,000.00

  • Target Investment:

    $25,000,000.00

Education

Lists including Luke

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

AT
AE
AE
AL

All Pre-Seed Investors

7974 people

Investments

Photys Therapeutics

Series A

Total Funding: $75M

Umoja Biopharma

Series A

Total Funding: $53M

Werewolf Therapeutics

Series A

Total Funding: $130M

Harpoon Therapeutics

Series B

Total Funding: $120M

Oncorus

Series A

Total Funding: $77M

Idun Pharmaceuticals

Series B

Total Funding: $50M

Work Experience

AC
Annulus Cellars

2020

  • Proprietor

    2020

WT
Werewolf Therapeutics

2016

  • Chairperson

    2016

    Founder, Start-up CEO, Chairman

MC
MPM Capital

1997

  • Managing Director

    1997

SR
Scleroderma Research Foundation

1999

  • Chairperson

    1999

Accel Partners

1990 - 1997

  • General Partner

    1990 - 1997